SS Innovations International (SSII) Income from Continuing Operations (2016 - 2026)
SS Innovations International's (SSII) quarterly Income from Continuing Operations came in at 3582571.0 in Q1 2026, up 36.94% year-on-year from 2616130.76 in Q1 2025, and down 122.02% quarter-over-quarter from 16270105.0 in Q4 2025.
SS Innovations International (SSII) Income from Continuing Operations (2016 - 2026) Analysis & Trends
SS Innovations International has disclosed Income from Continuing Operations across 11 years of filings, most recently posting 3582571.0 for Q1 2026.
- Income from Continuing Operations for Q1 2026 came in at 3582571.0, up 36.94% year-over-year; the trailing twelve-month figure through Mar 2026 was 8712879.0 (up 129.13% YoY), and the FY2025 annual result was 2606194.0, up 113.61% from the prior year.
- Income from Continuing Operations came in at 3582571.0 for Q1 2026 at SS Innovations International, down from 16270105.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 16270105.0 in Q4 2025 to a low of 16845069.0 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 2173238.0 (2024), against an average of 2741068.59.
- Across the five-year window, Income from Continuing Operations tumbled 1532.68% in 2023 and jumped 196.59% in 2025, its largest moves.
- SS Innovations International's Income from Continuing Operations stood at 1028208.0 in 2022, then plunged by 1080.91% to 12142250.0 in 2023, then slumped by 38.73% to 16845069.0 in 2024, then jumped by 196.59% to 16270105.0 in 2025, then sank by 122.02% to 3582571.0 in 2026.
- The last three Income from Continuing Operations figures came in at 3582571.0 (Q1 2026), 16270105.0 (Q4 2025), and 3717964.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | SS Innovations International | 689.95 Mn | 666.34 Mn | 5.33 Mn | -3.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.58 Mn |
| Dec 31, 2025 | 16.27 Mn |
| Sep 30, 2025 | -3.72 Mn |
| Jun 30, 2025 | -256,691.00 |
| Mar 31, 2025 | -5.68 Mn |
| Dec 31, 2024 | -16.85 Mn |
| Sep 30, 2024 | -3.25 Mn |
| Jun 30, 2024 | -4.14 Mn |
| Mar 31, 2024 | -2.17 Mn |
| Dec 31, 2023 | -12.14 Mn |
| Sep 30, 2023 | -1.90 Mn |
| Jun 30, 2023 | -5.52 Mn |
| Mar 31, 2023 | -1.31 Mn |
| Dec 31, 2022 | -1.03 Mn |
| Sep 30, 2022 | -486,386.00 |
| Jun 30, 2022 | -752,025.00 |
| Mar 31, 2022 | -80,421.00 |
| Dec 31, 2021 | -352,956.00 |
| Sep 30, 2021 | -418,209.00 |
| Jun 30, 2021 | -412,314.00 |